<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00150865</url>
  </required_header>
  <id_info>
    <org_study_id>CP 02-01</org_study_id>
    <nct_id>NCT00150865</nct_id>
  </id_info>
  <brief_title>Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery</brief_title>
  <official_title>Study of Posterior Lumbar Plexus Block for Pain Relief After Hip Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <brief_summary>
    <textblock>
      Compare lumbar plexus block with ropivacaine 0.475%, 0.4 ml/kg to saline. Each group
      randomized, includes 30 patients. block performed preoperatively Surgery under general
      anesthesia. Postoperative evaluation of pain (VAS) as first endpoint, and also morphine
      consumption via PCA device. Follow-up : 24h.

      Expectation : sizeable reduction of pain with block, of duration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Compare lumbar plexus block (randomized)

        -  ropivacaine 0.475%, 0.4 ml/kg

        -  saline 0.4 ml/kg . Each group includes 30 patients.

      Block performed preoperatively.

      Surgery under general anesthesia (sufentanil, propofol, atracurium ; maintenance :
      sevoflurane and nitrous oxide in O2. Sufentanil added peroperatively as clinically needed.

      Postoperative evaluation of pain (VAS, by an independant blind observer) as first endpoint,
      and also morphine consumption via PCA device.

      Adverse effects (nausea, vomiting, etc) recorded

      Follow-up : 24h. Expectation : sizeable reduction of pain with block, of duration.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date>March 2002</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>decrease of postoperative pain</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>decrease in morphine consumption</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duraration of analgesic effect</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Pain</condition>
  <condition>Postoperative</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adults

          -  ASA 1-3

        Exclusion Criteria:

          -  cognitive impairement

          -  ASA IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>laurent beydon, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ibrahim okais, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique St Leonard</affiliation>
  </overall_official>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>October 30, 2017</last_update_submitted>
  <last_update_submitted_qc>October 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <keyword>ropivacaine</keyword>
  <keyword>posterior lumbar plexus block</keyword>
  <keyword>hip arthroplasy</keyword>
  <keyword>analgesia</keyword>
  <keyword>postoperative</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

